130 related articles for article (PubMed ID: 34109599)
1. MicroRNA-185 inhibits cell proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Six2.
Zhu SM; Chen CM; Jiang ZY; Yuan B; Ji M; Wu FH; Jin J
Eur Rev Med Pharmacol Sci; 2021 May; 25(10):3640. PubMed ID: 34109599
[TBL] [Abstract][Full Text] [Related]
2. The role of miR-99b in mediating hepatocellular carcinoma invasion and migration.
Liu CJ; Yang JH; Huang FZ; Yang JH; Liu CP; Mao XH; Yi WM; Shen XB; Peng C; Chen MF; Jiang B; Wu JS
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7909. PubMed ID: 32767303
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-218 regulates the epithelial-to-mesenchymal transition and the PI3K/Akt signaling pathway to suppress lung adenocarcinoma progression by directly targeting BMI-1.
Xu L; Sun HB; Xu ZN; Han XL; Yin YY; Zheng Y; Zhao Y; Wang ZX
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):2827. PubMed ID: 33877684
[TBL] [Abstract][Full Text] [Related]
4. LncRNA ZEB2-AS1 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma cell through miR-574-3p/HMGA2 axis.
Xu JH; Chen RZ; Liu LY; Li XM; Wu CP; Zhou YT; Yan JD; Zhang ZY
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3397. PubMed ID: 34002806
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-32 inhibits the proliferation, migration and invasion of human colon cancer cell lines by targeting E2F transcription factor 5.
Yang F; Chen L; Wang ZJ
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):568. PubMed ID: 33577001
[TBL] [Abstract][Full Text] [Related]
6. MiR-30 suppresses lung cancer cell 95D epithelial mesenchymal transition and invasion through targeted regulating Snail.
Fan MJ; Zhong YH; Shen W; Yuan KF; Zhao GH; Zhang Y; Wang SK
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9234. PubMed ID: 33015755
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-199 inhibits proliferation and promotes apoptosis in children with acute myeloid leukemia by mediating caspase-3.
Xue F; Zhu Y; Xu F; Zhou LJ; Han F; Wang SC
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9769. PubMed ID: 33090443
[TBL] [Abstract][Full Text] [Related]
8. LncRNA LINP1 promotes proliferation and inhibits apoptosis of gastric cancer cells by repressing RBM5.
Lu XC; Zhou HY; Wu J; Jin Y; Yao XM; Wu XY
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7205. PubMed ID: 32706043
[TBL] [Abstract][Full Text] [Related]
9. LncRNA-HEIH suppresses hepatocellular carcinoma cell growth and metastasis by up-regulating miR-199a-3p.
Wu MM; Shen WD; Zou CW; Chen HJ; Guo HM
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6161. PubMed ID: 34730191
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of lncRNA SNHG7 inhibits proliferation and invasion of nasopharyngeal carcinoma cells through repressing ROCK1.
Wang L; Xu T; Cui X; Han M; Zhou LH; Wei ZX; Xu ZJ; Jiang Y
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7917. PubMed ID: 32767310
[TBL] [Abstract][Full Text] [Related]
11. MiRNA-488-3p inhibits malignant progression of NSCLC by modulating ADAM9.
Wu Y; Wu Y; Chen XY; Niu YX; Lv FZ; Gao W
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):2829. PubMed ID: 33877686
[TBL] [Abstract][Full Text] [Related]
12. Circ_0017247 accelerates epithelial-mesenchymal transition in non-small cell lung cancer.
Li CH; Wang YB; Chen KB
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7217. PubMed ID: 32706055
[TBL] [Abstract][Full Text] [Related]
13. Effect and mechanism of propofol in hepatic ischemia/reperfusion injury of rat.
Wei L; Chen WY; Hu T; Tang YX; Pan BB; Jin M; Kong GY
Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4185. PubMed ID: 34227082
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA CASC2 inhibits metastasis and epithelial to mesenchymal transition of lung adenocarcinoma via suppressing SOX4.
Wang D; Gao ZM; Han LG; Xu F; Liu K; Shen Y
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7210. PubMed ID: 32706048
[TBL] [Abstract][Full Text] [Related]
15. LncRNA SNHG7 promotes the proliferation and inhibits apoptosis of renal cell cancer cells by downregulating CDKN1A.
Dong JS; Wu B; Jiang B
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7556. PubMed ID: 32744661
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-191-5p promotes the development of osteosarcoma via targeting EGR1 and activating the PI3K/AKT signaling pathway.
Chen B; Zheng ZY; Yang JZ; Li XG
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3145. PubMed ID: 33928592
[TBL] [Abstract][Full Text] [Related]
17. Effects of microRNA-21 targeting PITX2 on proliferation and apoptosis of pituitary tumor cells.
Cui M; Zhang M; Liu HF; Wang JP
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7547. PubMed ID: 32744652
[TBL] [Abstract][Full Text] [Related]
18. CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p.
Zhang SJ; Ma J; Wu JC; Hao ZZ; Zhang YN; Zhang YJ
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3150. PubMed ID: 33928597
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA_LARP4 inhibits cell proliferation and invasion of nasopharyngeal carcinoma by repressing ROCK1.
Pan JY; Bao XL; Zhu K
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12624. PubMed ID: 33378005
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of long noncoding RNA DLX6-AS1 inhibits migration and invasion of thyroid cancer cells by upregulating UPF1.
Zhong ZB; Wu YJ; Luo JN; Hu XN; Yuan ZN; Li G; Wang YW; Yao GD; Ge XF
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8246. PubMed ID: 32894527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
